The novel class of GLP-1 receptor agonist and GIP co-agonist medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising improvements in diabetes treatment . https://peptide-skincare207624.neoncatblog.com/48115/tirzepatide-a-thorough-review